Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06902272
What this trial is testing

CtDNA to Predict Response to Chemo-Immunotherapy and Detect Minimal Residual Disease in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Miami 30
Large-scale testing (Phase 3)UnknownNCT01014130
What this trial is testing

Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Trans Tasman Radiation Oncology Group 101
Testing effectiveness (Phase 2)UnknownNCT02605811
What this trial is testing

Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerMetastatic Carcinoma
Guangzhou Medical University 426
Testing effectiveness (Phase 2)Study completedNCT00191763
What this trial is testing

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-Lung Cancer
Eli Lilly and Company 52
Not applicableStudy completedNCT00303914
What this trial is testing

Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer

Who this might be right for
Breast CancerCognitive/Functional EffectsColorectal Cancer+4 more
Eastern Cooperative Oncology Group 2,310
Testing effectiveness (Phase 2)Study completedNCT02581787
What this trial is testing

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung Carcinoma
Maximilian Diehn 28
Large-scale testing (Phase 3)Looking for participantsNCT07182682
What this trial is testing

Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery

Who this might be right for
Non-Small Cell Lung Cancer
Dizal (Jiangsu) Pharmaceutical Co., Ltd. 360
Large-scale testing (Phase 3)Study completedNCT00003279
What this trial is testing

Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 500
Not applicableLooking for participantsNCT07309211
What this trial is testing

Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

Who this might be right for
SCLC, Limited Stage
The First Affiliated Hospital with Nanjing Medical University 25
Testing effectiveness (Phase 2)Ended earlyNCT01138722
What this trial is testing

Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial

Who this might be right for
Early Stage Non-small Cell Lung Cancer
University Hospital, Ghent 1
Very early researchNot Yet RecruitingNCT07498439
What this trial is testing

TILs Therapy for Multiple Primary Early-Stage NSCLC

Who this might be right for
Primary Early-stage Non-small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07091305
What this trial is testing

QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)ChemoradiotherapyInduction Therapy+1 more
Shanghai Chest Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07200154
What this trial is testing

Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

Who this might be right for
Limited-stage Small-cell Lung CancerConcurrent Chemoradiation Therapy
Peking University Cancer Hospital & Institute 30
Not applicableStudy completedNCT00899028
What this trial is testing

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Who this might be right for
Lung Cancer
Vanderbilt University Medical Center 689
Large-scale testing (Phase 3)Study completedNCT00061919
What this trial is testing

Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University College, London 724
Testing effectiveness (Phase 2)Temporarily pausedNCT02470065
What this trial is testing

Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 38
Testing effectiveness (Phase 2)UnknownNCT04543890
What this trial is testing

A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Zhejiang Cancer Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT06371482
What this trial is testing

Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)

Who this might be right for
SCLC, Limited Stage
Hebei Medical University Fourth Hospital 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT05894889
What this trial is testing

Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC

Who this might be right for
Stage IIIB(N2) Non-small Cell Lung CancerStage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung Cancer+1 more
Peking University 70
Testing effectiveness (Phase 2)Study completedNCT00282022
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vion Pharmaceuticals 87
Next Page